Cerebral Blood Flow and Metabolism (Japanese journal of cerebral blood flow and metabolism)
Online ISSN : 2188-7519
Print ISSN : 0915-9401
ISSN-L : 0915-9401
Symposium 2 Brain Protection and Neural Repair
Effect of cilostazol for warfarin-induced hemorrhagic infarction in mice
Akira KitashojiHideaki Hara
Author information
JOURNAL FREE ACCESS

2014 Volume 25 Issue 2 Pages 57-61

Details
Abstract

The establishment of the treatment for warfarin-induced hemorrhagic infarction is essential because there is no effective treatment for hemorrhagic infarction at present and an exacerbation of hemorrhagic infarction with warfarin is mortal. Cilostazol, an antiplatelet agent, have various protective effects, including neuroprotective effect and protective effects on vascular endothelial cells, however it is careful administration for warfarin treatment patients. In the present study, we found that cilostazol suppressed the exacerbation of warfarin-induced hemorrhagic infarction by the enhancement of tight junction proteins and VE-cadherin. Furthermore, we suggested that this combination treatment is available clinically because this combination treatment was not extend bleeding time from the murine tail vein.

Content from these authors
© 2014 The Japanese Society of Cerebral Blood Flow and Metabolism
Previous article Next article
feedback
Top